← Back to Search

Cognitive Training

Computerized Cognitive Training for Psychosis (STEP (P4) Trial)

N/A
Recruiting
Led By Sophia Vinogradov, MD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, immediately after the intervention, 5 month follow up
Awards & highlights
No Placebo-Only Group

Summary

This trial will examine how people with/without psychotic illness process information about their environment and if cognitive training can help.

Who is the study for?
This trial is for individuals aged 15-40 with a recent diagnosis of psychosis or related conditions, who speak English and have an IQ above 70. They must be clinically stable, not pregnant, non-dependent on substances, and without major medical or neurological issues.
What is being tested?
The study is testing two types of computerized cognitive training designed to improve information processing in young adults with psychotic illnesses compared to those without psychiatric diagnoses.
What are the potential side effects?
Since the intervention involves cognitive training exercises, side effects are minimal but may include eye strain, headache or fatigue from computer use.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, immediately after the intervention, 5 month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, immediately after the intervention, 5 month follow up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in EEG Variables
Change in MRI Variables
Change in Performance of Bandit Task Variant
+2 more
Secondary study objectives
Change in Test My Brain Neurocognitive Assessment performance: Digit Symbol Matching Z Score
Change in Test My Brain Neurocognitive Assessment performance: Matrix Reasoning Z Score
Change in Test My Brain Neurocognitive Assessment performance: Multiracial Emotion Identification Z Score
+9 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Visual Cognitive Control TrainingExperimental Treatment1 Intervention
Training will involve maintaining accurate representations of cognitive context (the "rule") in working memory during response selection. On each training trial, participants must observe stimuli, and hold the correct response context "on-line" in order to select the correct response from among the stimuli. Training is adaptive using a staircase function, such that two consecutive correct responses increases either the speed of stimuli presentation or the working memory load via an increased number of stimuli that are presented; one incorrect response reduces the cognitive load. Each session will consist of 45 exercises requiring \~45 minutes.
Group II: Perceptual Discrimination TrainingExperimental Treatment1 Intervention
Training will involve Gabor patch and other visual stimuli discrimination exercises that focus on improving signal-to-noise resolution and attentional control with minimal working memory/cognitive control effects. On each training trial, participants are required to distinguish a target stimulus among a set of distractor stimuli. The similarity between target and distractors increases in level of difficulty based on an adaptive perceptual processing staircase function. Consecutive correct responses lead to increased modulation of the distractors to be more similar to the target, while 1 incorrect response drops the user to an easier level. Difficulty is adapted to maintain an 80% correct response rate. Each session will consist of 4 exercises requiring \~45 minutes. with 40 trials for each exercise.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Computerized Cognitive Training
2019
N/A
~410

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,439 Previous Clinical Trials
1,621,758 Total Patients Enrolled
11 Trials studying Psychosis
1,425 Patients Enrolled for Psychosis
National Institute of Mental Health (NIMH)NIH
2,936 Previous Clinical Trials
2,751,441 Total Patients Enrolled
47 Trials studying Psychosis
10,593 Patients Enrolled for Psychosis
Sophia Vinogradov, MDPrincipal InvestigatorUniversity of Minnesota
13 Previous Clinical Trials
3,250 Total Patients Enrolled
8 Trials studying Psychosis
1,500 Patients Enrolled for Psychosis
Angus MacDonald III, Ph.D.Principal InvestigatorUniversity of Minnesota
1 Previous Clinical Trials
350 Total Patients Enrolled
1 Trials studying Psychosis
350 Patients Enrolled for Psychosis

Media Library

Computerized Cognitive Training (Cognitive Training) Clinical Trial Eligibility Overview. Trial Name: NCT05664594 — N/A
Psychosis Research Study Groups: Perceptual Discrimination Training, Visual Cognitive Control Training
Psychosis Clinical Trial 2023: Computerized Cognitive Training Highlights & Side Effects. Trial Name: NCT05664594 — N/A
Computerized Cognitive Training (Cognitive Training) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05664594 — N/A
~19 spots leftby Mar 2025